Prevalence of visual symptoms among patients with newly diagnosed cytomegalovirus retinitis

Retina

Volumn 22, Issue 3, 2002, Pages 278-282

  Wei, Lisa L ^a   Park, Susanna S ^a   Skiest, Daniel J ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Cytomegalovirus retinitis; Human immunodeficiency virus (HIV)

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; EYE PAIN; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETINITIS; SCOTOMA; SYMPTOMATOLOGY; VISUAL DISORDER; VISUAL IMPAIRMENT;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TEXAS; VISION DISORDERS;

EID: 0036627395     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200206000-00004     Document Type: Article

References (20)

1. Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 1995;93:623-683.
2. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 5: clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmol 1997;124:141-157.
3. Centers for Disease Control and Prevention. Update: trends and AIDS incidence, death, prevalence - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:165-173.
4. Palella FJ Jr, Delaney KM, Moorman AC, The HIV Outpatients Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
5. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine: the Zidovudine Epidemiology Study Group. J Infect Dis 1992;166:1223-1227.
6. d'Arminio Monforte A, Mainini F, Testa L, et al. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS 1997;11:517-524.
7. Saillour F, Bernard N, Dequae-Merchadou L, et al. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine cohort in France, 1985 to 1994. J Acquir Immune Defic Syndr 1998;17:171-178.
8. Lyles RH, Chu C, Margolick J, et al. HIV RNA and CD4 lymphocyte count relate differently to the occurrence of PCP, CMV, and MAC disease [abstract no. 256]. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, February 1-5, 1998.
9. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996;114:821-827.
10. Kuppermann BD, Petty JD, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-582.
11. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997;124:227-233.
12. Holland GN, Buhles WC, Mastre B, et al. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Arch Ophthalmol 1989;107:1759-1766.
13. Wohl DA, Pedersen S, van der Horst CM. Routine ophthalmologic screening for cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr 2000;23:438.
14. Baldassano V, Dunn JP, Feinberg J, et al. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med 1995;333:670.
15. Shinkai M, Bozzette SA, Powderly W, et al. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis 1997;175:302-308.
16. Bowen EF, Sabin CA, Wilson P, et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 1997;11:889-893.
17. Tufail A, Moe AA, Miller MJ, et al. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1999;106:133-141.
18. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997;124:199-205.
19. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-1445.
20. Jabs DA, Bolton SG, Dunn JP, Palestine AG. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 1998;126:817-822.